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Abstract
Asthma is a heterogeneous outcome and how the condition should be measured to best capture clinically relevant disease
in epidemiologic studies remains unclear. We compared three methods of measuring asthma in the Danish National Birth
Cohort (n.50.000). When the children were 7 years old, the prevalence of asthma was estimated from a self-administered
questionnaire using parental report of doctor diagnoses, ICD-10 diagnoses from a population-based hospitalization registry,
and data on anti-asthmatic medication from a population-based prescription registry. We assessed the agreement between
the methods using kappa statistics. Highest prevalence of asthma was found using the prescription registry (32.2%)
followed by the self-report (12.0%) and the hospitalization registry (6.6%). We found a substantial non-overlap between the
methods (kappa=0.21–0.38). When all three methods were combined the asthma prevalence was 3.6%. In conclusion, self-
reported asthma, ICD-10 diagnoses from a hospitalization registry and data on anti-asthmatic medication use from a
prescription registry lead to different prevalences of asthma in the same cohort of children. The non-overlap between the
methods may be due to different abilities of the methods to identify cases with different phenotypes, in which case they
should be treated as separate outcomes in future aetiological studies.
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Introduction
Recent decades have shown a concerning increase in the
prevalence of asthma in both developed and developing countries
[1–3]. According to the WHO, asthma is now one of the most
common chronic respiratory diseases worldwide and can lead to
reduced life quality for the affected individual as well as increasing
health care costs for society [4].
Asthma is a complex and poorly defined syndrome character-
ized by several phenotypes, possibly with different aetiologies
[5,6]. There is currently no ‘‘gold standard’’ for the measurement
of asthma and how the condition should be defined and measured
in epidemiologic studies remains unclear. Most previous studies
have used self-administered questionnaires to define asthma [7].
Questionnaires are useful in epidemiologic studies because of low
costs, permitting larger sample sizes compared to intensive and
expensive data collection methods, including bronchial challenge
tests and reversibility tests [7,8]. However, the appropriateness of
using self-reported data to measure asthma in aetiological studies
has been debated, mainly due to problems associated with recall of
events and individual differences in symptom perception [9]. In
Scandinavia, there is also the possibility of using population-based
register data to obtain information about asthma [10,11]. These
registries can be useful as they do not depend on recall and allow
for complete follow-up.
This study aimed to determine the prevalence of asthma in a
population of children using three classification methods, including
self-report, population-based hospitalization data, and population-
based prescription data in a large prospective birth cohort, and to
determine the agreement between the methods.
Methods
Study Population and Design
The study is based on a follow-up of the Danish National Birth
Cohort that enrolled more than 100,000 pregnancies from 1996–
2003 and has been described in detail elsewhere [12,13]. A
comprehensive follow-up questionnaire that included standardized
questions on asthma from a large worldwide collaboration study,
the International Study of Asthma and Allergies in Childhood
(ISAAC), was mailed to the mothers when the children were 7
years old. In total, 93,616 mother-child pairs were included in the
follow-up and answers were obtained for 53,637 children (57%).
Mothers provided written informed consent on behalf of their
children. The Regional Scientific Ethics Committee for the
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Centre       for        Fetal      Programming,    Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark,municipalities of Copenhagen and Frederiksberg approved all
study protocols, and all procedures were in accordance with the
Declaration of Helsinki.
Measures of Asthma
Self-reported asthma was assessed from the follow-up
questionnaire when the children were 7 years old. We defined
a self-reported asthma case as a child with a positive answer to
the question ‘‘Has a doctor ever said that your child had asthma?’’.
Current self-reported asthma was defined as a child with a self-
reported doctor diagnosis of asthma plus a positive answer to
the question ‘‘Has your child had any wheezing symptoms within the
past 12 months?’’.
We used the unique Danish Personal Identification Number
(CPR number) to extract information about asthma from two
population-based registers: the Danish National Patient Register
(DNPR) and the Register of Medicinal Product Statistics (RMPS).
Information about hospital contacts was extracted from the
DNPR, which includes mandatory information about all hospital
admissions in Denmark collected since 1977, and since 1995, also
emergency room and outpatient contacts. Diagnoses of asthma
were based on the International Classification of Diagnosis system
10 (ICD-10). We defined a hospitalization case of asthma as a
child who had an asthma diagnosis (J45.0, J45.1, J45.2, J45.8,
J45.9, or J46.9) registered in the DNPR from birth to 7 years of
age. Only the first registered asthma case was used.
Information about asthma medication use was extracted from
the RMPS, which includes mandatory information about all
prescriptions redeemed at Danish pharmacies since 1995.
Medication use was based on the Anatomical Therapeutic
Chemical Classification System (ATC). We extracted information
using the following ATC codes: R03A, R03B, R03C, and R03D.
We used a previously validated definition of asthma based on
prescription data [14]. We defined a prescription case of asthma as
a child who had redeemed any type of anti-asthmatic drug except
for beta2-agonists as liquid, inhaled beta2-agonists only once or
inhaled steroid only once from birth to 7 years of age. Similarly to
the DNPR, only the first registered case of asthma was used.
Statistical Methods
We calculated the 7-year prevalences of asthma by classification
method and for the methods in combination. The prevalence
according to the registries was calculated for the complete study
population; that is 93,616 children, whereas the self-reported
prevalence was calculated for those who had filled out the
questions on asthma.
Asthma cases from the three classification methods were
compared in two-by-two tables and the agreement among cases
and non-cases for each method calculated. We looked at all
possible combinations of the classification methods and therefore
alternatively used each of the three methods as the comparison
measure or ‘gold standard’. Cohen’s kappa coefficient was
calculated to describe the overall agreement between the
classification methods.
In supplementary analyses we modified the case definitions of
asthma in order to ascertain possible phenotypes. Current self-
reported asthma was compared to cases ascertained by the
registries, excluding the first 3 years of age from the register data.
We expected that the modified definitions would to a larger extent
reflect current asthma and exclude transient or viral wheeze
diagnosed as asthma in early childhood which later resolved.
All analyses were carried out in SAS statistical software (version
9.2; SAS Institute, Cary, North Carolina).
Results
Asthma Prevalence
The 7-year prevalence of asthma for each classification method
is shown in Table 1. The prevalence of self-reported asthma was
12.0%; of those 11.7% were currently experiencing wheezing
symptoms. According to the hospitalization registry the asthma
prevalence was 6.6%. The prescription registry yielded a
prevalence of 32.7%. We found a substantial non-overlap between
the cases ascertained by the three classification methods. Only
3.6% of the children were classified as cases during the first 7 years
of age when all three classification methods were combined
(Figure 1).
Classification Agreement
The overall agreement between self-reported asthma cases
compared with cases ascertained by the hospitalization registry
(k=0.38) and the prescription registry (k=0.37) was similar
(Table 2). The overall agreement between cases ascertained by
the two registries was lower (k=0.21).
Among cases identified in the hospitalization registry and the
prescription registry, the proportion of children who also had a
self-reported doctor diagnosis of asthma was 65% and 33%,
respectively (Table 3). If the self-reported cases were used as the
reference, the proportions of cases also classified by the
hospitalization registry and the prescription registry were 31%
and 86%, respectively. 17% of the prescription cases were also
hospital cases, whereas 90% of hospital cases were classified as
cases by the prescription registry. In general, the three methods
showed better agreement with regard to classifying non-cases with
the proportions of agreement ranging from 72–99%.
Supplementary Analyses
Table 4 shows the results from the supplementary analyses
where registry information on the first 3 years of life was excluded.
This modification of the case definitions did not change the overall
agreements between the methods. Highest overall agreement was
found between current self-reported asthma and the prescription
registry (kappa=0.35), followed by the agreement between current
self-reported asthma and the hospitalization registry (kap-
pa=0.29), whereas the lowest agreement was found between the
two registries (kappa=0.21). The agreement between cases was
lower for all comparisons compared to the measures that included
the first 3 years of life (15–57% vs. 27–90%) whereas the
agreement between non-cases remained high (93–99% vs. 72–
99%).
Discussion
To our knowledge, this is the largest population-based study to
simultaneously employ and compare three different asthma
classification methods that are commonly used separately in
epidemiological studies. Case ascertainment by means of self-
report, a hospitalization registry, and a prescription registry
yielded variable estimates of asthma prevalence during the first 7
years of age ranging from 6.6%–32.7%. Moreover, our study
revealed a substantial non-overlap between cases identified by the
three methods resulting in a prevalence of 3.6% if all three
methods were combined to define asthma. Measures of agreement
were low (kappa=0.21–0.38).
Prevalence measures of asthma are difficult to compare across
settings because of the lack of a ‘‘gold standard’’. Another Danish
study that employed ICD-10 codes of asthma in the DNPR found
a prevalence of 5.0% of asthma in a cohort of children followed
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findings, despite an older study population. A population-based
study from Norway that used data on prescriptions on anti-
asthmatic medication from the Norwegian Prescription Database
found a 12-month asthma prevalence of 9.1% among all
Norwegian children aged 0–19 [16]. Compared to the prescription
data prevalence reported in the present study, the Norwegian
prevalence seems low, but this may be explained by the quite
different outcome definitions and prevalence measures that were
employed in the two studies. In a population of Canadian children
aged 5 to 9 years, Yang et al. found a prevalence of asthma by self-
reports of 15.7% and 21.1% using health claims [17]. The same
question from the ISAAC questionnaire was used to define self-
reported asthma as in our study. The health claims diagnosis was
defined as at least one hospitalization for asthma at any time
during the child’s life or two separate ambulatory or emergency
room visits for asthma within a two year frame and had been
validated against an expert consensus diagnosis of asthma [18].
While the self-report prevalence concurs quite well with our
findings, the prevalence of the asthma health claims diagnosis
cannot be directly compared to any of our results, since our
registry data do not include primary care physicians’ diagnoses,
whereas the employed Canadian health claims data do [18].
Overall, studies using self-report of asthma have yielded a range
of different prevalences, illustrated for example by the ISAAC
study, which reported 12-months prevalences of asthma ranging
from 1.6–36.8% using the same standardized questionnaire in
different populations [19].
The overall agreement of the asthma classification methods in
our study was low, with kappa-values below 0.40 for all
comparisons. This is in contrast to the results reported in the
aforementioned study by Yang et al. that compared self-reported
asthma with asthma diagnosis based on health claims data and
found an overall agreement of kappa=0.60 [17]. The better
agreement with self-report in the study by Yang et al. may be due
to the inclusion of primary care physicians’ diagnoses which are
lacking in our study. However, as in our study, the agreement
between the methods was higher when classifying non-cases.
A recent study by Nwaru et al. compared self-reported measures
of asthma from a Finnish version of the ISAAC questionnaire with
purchase of at least one anti-asthmatic medication during the
preceding 12monthsand foundthat theself-reportedmeasures had
a98%agreementbothwithregardtoclassifyingcasesandnon-cases
ofasthma[20].Self-reportedasthmawasdefinedasachildwithany
wheezing symptom or use of asthma medication during the
preceding 12 months plus ever asthma (with or without a doctor
confirmation)andthedefinitionofasthmabasedontheprescription
registry included children with at least one prescription. The
definitions therefore differ from those used in our study, both with
regard to the prevalence period as well as the symptom-based
definitionwhichmayexplainthehigheragreementofthecompared
measures in the Finnish study. Other studies that have compared
Table 1. 7-year prevalence of asthma according to self-report, the Danish National Patient Register and the Register of Medicinal
Product Statistics.
Classification method N cases/N non-cases Prevalence %
Self-reports
‘Self-reported asthma’: diagnosis of asthma given by a doctor (n=53,637) 6,424/47,213 12.0%
‘Self-reported current asthma’: doctor diagnosis + current wheezing (n=19,146) 2,244/16,902 11.7%
Danish National Patient Register
Hospital cases (n=93,616) 5,861/87,755 6.6%
Register of Medicinal Product Statistics
Prescription cases (n=93,616) 30,099/63,517 32.2%
Combination of methods
Self-reported asthma + hospital cases + prescription cases (n=53,637) 1,935/51,207 3.6%
doi:10.1371/journal.pone.0036328.t001
Figure 1. Comparison of asthma cases classified by self-report, the
Danish National Patient Register (DNPR) and the Register of Medicinal
Product Statistics (RMPS) in 53,637 children.
doi:10.1371/journal.pone.0036328.g001
Table 2. Conditional distributions of asthma cases and non-
cases classified by self-report, the Danish National Patient
Register (DNPR) and the Registry of Medicinal Product
Statistics (RMPS).
Yes/Yes No/No Yes/No No/Yes Kappa
Self-report/DNPR 2,023 46,122 4,401 1,091 0.38
RMPS/Self-report 5,499 36,209 925 11,004 0.37
DNPR/RMPS 5,211 62,867 650 24,888 0.21
doi:10.1371/journal.pone.0036328.t002
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lower agreement between the methods [21,22].
The variable prevalence estimates across the three methods that
we employed, and the substantial non-overlap between the cases
they identified, are noteworthy. The correct interpretation of this
is hampered by the fact that we have not assessed the true
prevalence of asthma in our population which would require a
clinical assessment of each individual. It is reasonable to assume
that the three methods we employed may have different error
sources and thus variable degrees of misclassification for a given
biological phenotype. However, for the case definition using the
prescription register data, we used a validated definition of asthma
that has previously been shown in a study by Moth et al. to have a
specificity of 0.86 and a sensitivity of 0.63 compared with
discharge information and a questionnaire completed by general
practitioners in those without a discharge diagnosis [14]. For self-
reported measures, poor recall of past events could have affected
the results, although we believe this would not lead to any
systematic over- or underreporting of the conditions.
While different error sources may explain some of the variance
in the prevalences of asthma among the assessment methods, it is
also possible that the three methods identify asthma cases with
biologically distinct phenotypes. For example, the hospitalization
registry may capture more severe phenotypes than the prescription
registry or maternal self-report. The overrepresentation of more
severe cases when using this classification method may however be
appropriate for studies of aetiological associations if hospitalized
cases have a different phenotypical aetiology compared to the
cases identified using the other methods. In contrast, the
prescription registry may identify a heterogeneous mix of cases,
ranging from suspected asthma cases that may have been
prescribed anti-asthmatic medication to clarify a diagnosis to
more severe cases that continuously require anti-asthmatic
treatment. A study showed that 13.9% of all children in Denmark
aged 0–15 years had redeemed prescriptions of at least one anti-
asthmatic drug in one year but not all of these children had
received an asthma diagnosis leading to an overestimation of the
asthma prevalence [23]. This is also true for the self-reported
diagnosis for asthma that also may comprise a broad spectrum of
cases with respiratory symptoms ranging from mild to severe,
including wheezing.
Wheezing symptoms in young children aged 0–3 years are
common and many are prescribed anti-asthmatic mediations [24].
These wheezing symptoms are often transient or viral-induced and
later remit [5]. Including the transient wheezers in the asthma
measures may dilute possible associations between exposures and
clinically relevant asthma and this may have implications for
studies of aetiological associations. When we excluded the first
three years of life from the register data and compared it to current
self-reported asthma we did not, however, find an overall
increased agreement between the methods. This supports the
conclusion that the three methods may not identify the same
asthma cases and that the outcomes may represent different
phenotypes of asthma.
The extent to which the non-overlap between the methods may
be due to misclassification or, to different phenotypes being
identified by each method, has implications for how to use these
methods in studies where each individual has been assessed by
more than one method simultaneously. Assuming that the
methods identify a single phenotype, methods can be combined.
In aetiologic studies of asthma where the aim is to estimate a
relative risk for a given factor high specificity may be desirable
even at the expense of lower sensitivity; this could be obtained by
requiring that two or more methods agree on the asthma case
ascertainment. For example, the self-reported measures could be
used in combination with the prescription register definition to
Table 3. Agreement of asthma cases and non-cases classified by self-report, the Danish National Patient Register (DNPR) and the
Register of Medicinal Product Statistics (RMPS).
Agreement among cases Agreement among non-cases
Self-report vs. DNPR 65% 91%
DNPR vs. Self-report 31% 98%
Self-report vs. RMPS 33% 98%
RMPS vs. Self-report 86% 77%
DNPR vs. RMPS 17% 99%
RMPS vs. DNPR 90% 72%
doi:10.1371/journal.pone.0036328.t003
Table 4. Agreement of asthma cases and non-cases classified by self-report (current asthma), the Danish National Patient Register
(DNPR) and the Register of Medicinal Product Statistics (RMPS), excluding the first three years of age from the register data.
Agreement among cases Agreement among non-cases Kappa
Self-report/DNPR 57% 91% 0.29
DNPR/Self-report 25% 98% 0.29
Self-report/RMPS 38% 93% 0.35
RMPS/Self-report 51% 89% 0.35
RMPS/DNPR 57% 93% 0.21
DNPR/RMPS 15% 99% 0.21
doi:10.1371/journal.pone.0036328.t004
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prevalence of 10.2% On the other hand, assuming that the
methods identify different phenotypes we may need to do separate
analyses, one for each case definition.
In conclusion, our large-scale prospective study comparing
three different methods for asthma ascertainment revealed a
substantial non-overlap between cases identified by the three
methods. Reflective of either different biases or different pheno-
typical expressions of asthma, these classifications need to be
carefully considered when deciding on asthma outcomes in future
aetiological studies.
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